<DOC>
	<DOCNO>NCT00596154</DOCNO>
	<brief_summary>The purpose study determine safety new treatment offer study . PCNSL cure less half patient standard treatment , combination chemotherapy brain radiation . Also , combination chemotherapy brain radiation may result serious lasting side effect . Most patient old age 60 develop memory problem , difficulty walk inability control bladder . Some patient young age 60 also develop side effect .</brief_summary>
	<brief_title>Rituximab , Methotrexate , Procarbazine Vincristine Followed High-dose Chemotherapy With Autologous Stem-cell Rescue Newly-diagnosed Primary CNS Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Procarbazine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>All patient must nonHodgkin 's lymphoma involve brain , demonstrate CT MRI histologic confirmation one following : A positive CSF cytology lymphoma monoclonal lymphocyte population define cell surface marker . A biopsy vitreous uvea demonstrate nonHodgkin 's lymphoma . Brain biopsy . Patients must HIV1 negative . Patient must leave ventricular ejection fraction â‰¥ 50 % . Patients must evidence systemic lymphoma . This must demonstrate CT scan chest , abdomen pelvis prior registration . Patients must adequate bone marrow function ( defined peripheral leucocyte count &gt; 3000 cells/mm3 platelet count &gt; 100,000 cells/mm3 ) , liver function ( bilirubin &lt; 2.0 mg % ) , adequate renal function ( serum creatinine &lt; 1.5 mg/dl creatinine clearance &gt; 50cc/min/1.73M2 ) . Men woman reproductive potential must agree use acceptable method birth control treatment six month completion treatment . Patients must 18 72 yearsold . Patients must sign informed consent . Prior cranial irradiation Other active primary malignancy exception basal cell carcinoma skin cervical carcinoma situ . Preexisting immunodeficiency renal transplant recipient . Prior treatment chemotherapy CNS lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>72 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>